RE:All stocks take a bath….TFTheygonnasay wrote: from my DD Rvv's bucc works best at mitigating the symptoms and secondary effects of the virus like inflammation. The more big Pharma Attempts to attack the virus itself the worse the virus will get.
From your DD?
There is absolutely ZERO DD available regarding Bucillamine having some benefit in the COVID indication in any way. Only hype and conjecture.
The company has thus far not presued having the study unblinded. At 700 plus patients there should be enough data to unblind the study.
UNLESS the data is too close to call.
If the data is too close to call its a failure.
The Psilocybin industry in Canada (I realize you said the Canadian market has no value) is about to take off. It is this market, not covid hype, that pushed RVV to its high just over a year ago.
If anyone wants to look into the most likely value of this company, Psilocybin is where is lies.
FYI, I'm currently buying, I've added ~250k shares since the stock fell below .30 and will continue to purchase. I still see this having about 10% to the absolute floor of .24 cents. That said I am willing to risk the downside below 30 cents.
The possiblity of being able to sell shares for profit at this level is pretty much guaranteed.
IMO